Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Upper Facial Remodeling With Perlane-L and Dysport (DPL-2010)

This study has been completed.
Medicis Pharmaceutical Corporation
Information provided by (Responsible Party):
Beer, Kenneth R., M.D., PA Identifier:
First received: May 11, 2011
Last updated: September 24, 2013
Last verified: September 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2012
  Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)